97616 Bad Neustadt a.d. Saale, de
+49 (9771) 65-1327
RHÖN-KLINIKUM AG: Preliminary Results for Financial Year 2017*
- 836,387 patients treated
- Revenues amount to Euro 1.21 billion
- EBITDA stands at Euro 97.8 million
- Net consolidated profit amounts to Euro 36.7 million
- Optimistic outlook for 2018: increased profitability, RHÖN campus concept and digitalization strategy remain in focus
A total of 836,387 patients were treated in the RHÖN-KLINIKUM AG hospitals in financial year 2017. Corporate revenues stood at Euro 1.21 billion with earnings before interest, taxes, depreciation and amortization (EBITDA) amounting to Euro 97.8 million. Net consolidated profit was at Euro 36.7 million.
„The expected EBITDA for 2018 shows that we are on the right path. The package of measures which we commenced in the middle of last year continues to take effect and we remain committed to our operative in-house tasks. The agreement with the Federal State of Hesse and the universities in Giessen and Marburg regarding separate accounting offers new opportunities for the university hospitals in Giessen and Marburg (Universitätsklinikum Gießen und Marburg GmbH (UKGM)) and therefore also for the entire corporate group in the mid-term. 2018 stands for the implementation of our new campus concept in Bad Neustadt and the introduction of various digital instruments so that we can ease the workload of our employees and also make the treatment process faster and safer for our patients,” CEO Stephan Holzinger stated.
For the current financial year 2018 we expect revenues in the amount of Euro 1.24 billion plus/minus 5 percent.
A continuing burden on our company remains regulatory legislation such as lower remuneration for services with high material costs (especially cardiological services) or the fixed costs degression discount on additional services.
For 2018 we expect a much higher amount for earnings before interest, taxes, depreciation and amortization (EBITDA) of between Euro 117.5 million and Euro 127.5 million in comparison with 2017. EBITDA is positively influenced by the agreement with UKGM regarding separate accounting as well as other effects.
*Preliminary, not audited financial figures with possible rounding-off differences
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an email@example.com.